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Short Communication
Kidney disease is common in Cyprus, particularly familial kidney 
disease [1]. Most patients with familial disease have one of two 
clinical phenotypes, either (i) haematuric nephropathy with persistent 
microscopic haematuria, late-onset proteinuria and variable renal 
failure; or (ii) asymptomatic renal impairment in the absence of dipstick 
positive haematuria and proteinuria. Work from Deltas et al. has shown 
that for those with autosomal dominant haematuric nephropathy, 
mutations in the COL4A3/COL4A4 genes of type IV collagen or CFHR5 
are often found [2,3] and those where renal disease co-segregates with a 
normal urinalysis typically have autosomal dominant MUC1-associated 
tubulointerstitial kidney disease (formerly termed medullary cystic 
kidney disease type 1) [4]. Familial microscopic haematuria is caused 
by heterozygous COL4A3/COL4A4 mutations in approximately 40% of 
cases, suggesting that additional and still unknown genes are likely to 
be responsible for a similar phenotype [5]. Therefore, work is currently 
underway to investigate the Turkish Cypriot population for monogenic 
causes of these different phenotypes.
In this population, cystic kidney disease is also common. In 
pedigrees with COL4A3/COL4A4 mutations, multiple small and large 
renal cysts were found in an unusually large number of patients in 
four of the 11 families [6]. 40% of patients with autosomal dominant 
MUC1-associated tubulointerstitial kidney disease had evidence of 
renal cysts on ultrasound, as well as 27% of unaffected individuals [4]. 
Heterozygous mutations of the HNF1B gene are the commonest known 
monogenic cause of developmental kidney disease and renal cysts are 
the predominant renal phenotype [7]. HNF1B-associated disease is 
considered a multi-system disorder (Table 1) and early-onset diabetes 
mellitus is the most frequent extra-renal phenotype seen. The mean 
age at diagnosis of diabetes is 24 years [8], although this can range 
from the neonatal period [9] to late middle age [10]. Genetic changes 
comprise whole-gene deletions in approximately 50% of patients and 
base substitutions or small insertions/deletions within the HNF1B gene 
in the remainder [7]. Following the incidental finding of a missense 
mutation in HNF1B (G76C) in an elderly Cypriot male with multicystic 
kidneys, we aimed to perform HNF1B genetic testing in 11 individuals 
from the Turkish Cypriot population with renal cysts and diabetes plus 
a family history of either renal disease or diabetes.
Patients from the Turkish Cypriot community were recruited 
from outpatient clinics in north Cyprus. Inclusion criteria included 
the presence of unexplained renal disease with diabetes and a family 
history of renal disease (unexplained renal impairment or cysts) and/
or diabetes in at least one first degree relative. Informed written consent 
was obtained from all participants and the study was conducted 
in agreement with the Declaration of Helsinki Principles. Basic 
clinical information was collected and blood samples were taken for 
DNA extraction. Mutation screening of HNF1B was performed by 
sequencing of coding exons and exon-intron boundaries together 
with gene dosage assessment by multiplex ligation-dependent probe 
Organ Phenotype
Kidney
•	 Developmental kidney disease
•	 Bilateral hyperechogenic kidneys on prenatal 
ultrasonography
•	 Renal cysts
•	 Single kidney
•	 Renal hypoplasia
•	 Other: horseshoe and duplex kidneys, collecting system 
abnormalities, bilateral hydronephrosis
Electrolyte abnormalities
•	 Hypomagnesaemia
•	 Hyperuricaemia (and early-onset gout)
Pancreas
Early-onset diabetes mellitus 
Pancreatic hypoplasia
•	 Hypoplasia of body and tail of pancreas with slightly 
atrophic head
•	 Pancreatic exocrine dysfunction, which is often subclinical
Genital tract
Genital tract malformations
•	 Bicornuate uterus
•	 Uterus didelphys
•	 Rudimentary uterus
•	 Double vagina
•	 Vaginal aplasia
Liver
Abnormal liver function
•	 Asymptomatic rise in the levels of liver enzymes (common)
•	 Neonatal cholestasis (rare)
Brain*
Neurodevelopmental disorders
•	 Autism spectrum disorders
•	 Cognitive impairment
*Only in patients with an HNF1B whole-gene deletion occurring in the context of a 
larger 17q12 microdeletion
Table 1:  Clinical features seen in HNF1B-associated disease.
amplification as previously described [10,11]. Glomerular filtration rate 
(GFR) was estimated using the simplified Modification of Diet in Renal 
Disease formula in adults [12]. GFR was set at 0 for patients on renal 
replacement therapy.
11 unrelated patients participated in the study (Table 2); 8/11 
were males and the median age was 65 years (interquartile range 
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Patient Sex Current age (years) Renal phenotype
Age at 
detection of 
renal disease 
(years)1
eGFR
(ml/min/1.73 m2)2
Diabetes 
phenotype
Other phenotypic 
information
Family history3
Renal 
disease Diabetes
1 M 65 Renal cysts & low-grade proteinuria 55 40
DM detected at 
age 50 - +
2 M 64 Renal cysts 55 15 DM detected at age 50 + +
3 F 48
Renal cysts & 
stone disease 
with low-grade 
proteinuria & 
microscopic 
haematuria
90
DM detected at 
age 40; treatment 
with metformin
+ +
4 M 74
Renal cysts 
& asymmetric 
kidneys with ESRD
60 0 DM + -
5 M 76 Renal cysts & ESRD 60 0
DM detected at 
age 60 + +
6 M 73 Renal cysts 60 47 DM detected at age 60 + +
7 M 53 Possible renal cysts & ESRD 40 0 DM + -
8 F 60 Possible renal cysts & ESRD 45 0 DM
Learning difficulties, 
short stature & 
obesity
+ -
9 M 77 Renal cysts & ESRD 60 0 DM + -
10 M 65
Renal cysts & 
small left kidney 
with low-grade 
proteinuria & 
microscopic 
haematuria
60 63 DM detected at age 47 + +
11 F 69 Possible renal cysts & ESRD 0 Possible DM + -
1 Blank field denotes unknown information; 2 eGFR recorded as 0 if patient has ESRD; 3 Family history was recorded as present (+) or absent (-) depending on whether a 
first-degree relative was affected with renal disease or diabetes. Abbreviations: DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; ESRD, end-stage renal 
disease; F, female; M, male 
Table 2: Clinical features of the 11 study participants.
[IQR] 62-73.5). All patients had been diagnosed with renal cysts 
(although imaging was inconclusive in three cases) and the median age 
at diagnosis of renal disease was 60 years (IQR 55-60). 6/11 patients 
had end-stage renal disease and were established on haemodialysis; 
estimated GFR ranged from 15-90 ml/min/1.73 m2 in the remainder. 
Diabetes was present in all patients (possible diagnosis in one case 
only); the age at diagnosis ranged from 40-60 years. Both sequencing 
and dosage analysis of the HNF1B gene were normal in all 11 patients.
No HNF1B gene mutations or deletions were identified in this 
series of 11 individuals from the Turkish Cypriot community with renal 
cysts and diabetes. The family history of renal disease or diabetes in 
first degree relatives is suggestive of a monogenic aetiology so it is likely 
that other causative genes remain to be found. The detection rate of 
HNF1B-associated renal disease ranges from 10-24% in study cohorts 
including adults of ≥50 individuals where both mutation and deletion 
screening of HNF1B was performed [10,11,13,14]. However, the adult 
participants in these studies tended to be younger and of either a White 
European or Asian background so the findings may not be relevant to 
this cohort of older patients from a Turkish Cypriot population.
Several limitations were associated with this work. The sample size 
was small so the absence of HNF1B gene anomalies in this group may 
have been due to chance alone. The clinical information available for 
patients was often very limited and the older age of participants meant 
an increased likelihood of more common pathologies, such as simple 
renal cysts and type 2 diabetes. HNF1B genetic testing was limited to 
a specific phenotype of renal cysts and diabetes; however, both the 
renal and extra-renal phenotype of HNF1B-associated disease is very 
variable so it may have been useful to study patients with a wider range 
of clinical features.
The increasing use of next generation sequencing, which enables 
sequencing of the entire human genome within several days, will 
be useful in this Turkish Cypriot community where there is a high 
incidence of familial kidney disease. New information from Cyprus 
on the genetic basis of renal disease will have a major impact on the 
identification of causes of renal impairment in neighbouring countries, 
where the aetiology is often unknown and the economic conditions do 
not allow for universal health care [15].
In summary, no HNF1B gene mutations or deletions were identified 
in a small cohort of 11 patients with renal cysts and diabetes from the 
Turkish Cypriot population where there is a high incidence of familial 
renal disease; this highlights the importance of continued investigation 
for novel genetic causes in this community.
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